SKY detection of chromosome rearrangements in two cases of tMDS with a complex karyotype

Cancer Genetics and Cytogenetics

Volumn 138, Issue 2, 2002, Pages 128-132

  Cohen, Ninette ^a   Trakhtenbrot, Luba ^a   Yukla, Mona ^b   Manor, Yosef ^b   Gaber, Elena ^b   Yosef, Gabi ^b   Amariglio, Ninette ^a   Rechavi, Gideon ^a   Amiel, Aliza ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CHROMOSOME 18; CHROMOSOME 5; CHROMOSOME ABERRATION; CLONE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPING; MARKER CHROMOSOME; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; SPECTRAL KARYOTYPING;

EID: 0037110132     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00532-0     Document Type: Article

References (22)

1. Ben-Yehuda D., Krichevsky S., Caspi O., Rund D., Polliack A., Abeliovich D., Zelig O., Yahalom V., Paltiel O., Or R., Peretz T., Ben-Neriah S., Yehuda O., Rachmilewitz E.A. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood. 88:1996;4296-4303.
2. Leone G., Mele L., Pulsoni A., Equitani F., Pagano L. The incidence of secondary leukemias. Haematologica. 84:1999;937-945.
3. Andersen M.K., Christiansen D.H., Jensen B.A., Ernst P., Hauge G., Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem. report on two new cases and review of the literature since 1992 Br J Haematol. 114:2001;539-543.
4. Horiike S., Taniwaki M., Misawa S., Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer. 62:1988;1129-1138.
5. Yunis J.J., Lobell M., Arnesen M.A., Oken M.M., Mayer M.G., Rydell R.E., Brunning R.D. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol. 68:1988;189-194.
6. Super H.J., McCabe N.R., Thirman M.J., Larson R.A., Le Beau M.M., Pedersen-Bjergaard J., Philip P., Diaz M.O., Rowley J.D. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood. 82:1993;3705-3711.
7. Pedersen-Bjergaard J., Philip P., Larsen S.O., Jensen G., Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood. 76:1990;1083-1091.
8. Rubin C.M., Arthur D.C., Woods W.G., Lange B.J., Nowell P.C., Rowley J.D., Nachman J., Bostrom B., Baum E.S., Suarez C.R.et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children. correlation between chromosomal abnormalities and prior therapy Blood. 78:1991;2982-2988.
9. Morel P., Hebbar M., Lai J.L., Duhamel A., Preudhomme C., Wattel E., Bauters F., Fenaux P. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system. a report on 408 cases Leukemia. 7:1993;1315-1323.
10. Fenaux P., Morel P., Lai J.L. Cytogenetics of myelodysplastic syndromes. Semin Hematol. 33:1996;127-138.
11. Garini Y., Macville M., du Manoir S., Buckwald R.A., Lavi M., Katzir N., Wine D., Bar-Am I., Schrock E., Cabib D., Rieg T. Spectral karyotyping. Bioimaging. 4:1996;65-72.
12. Kakazu N., Taniwaki M., Horiike S., Nishida K., Tatekawa T., Nagai M., Takahashi T., Akaogi T., Inazawa J., Ohki M., Abe T. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer. 26:1999;336-345.
13. Mohr B., Bornhauser M., Thiede C., Schakel U., Schaich M., Illmer T., Pascheberg U., Ehninger G. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia. 14:2000;1031-1038.
14. Cohen N., Betts D.R., Trakhtenbrot L., Niggli F.K., Amariglio N., Brok-Simoni F., Rechavi G., Meitar D. Detection of unidentified chromosome abnormalities in human neuroblastoma by spectral karyotyping (SKY). Genes Chromosomes Cancer. 31:2001;201-208.
15. Rao P.H., Cigudosa J.C., Ning Y., Calasanz M.J., Iida S., Tagawa S., Michaeli J., Klein B., Dalla-Favera R., Jhanwar S.C., Ried T., Chaganti R.S. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood. 92:1998;1743-1748.
16. Zattara-Cannoni H., Dufour H., Lepidi H., Chatel C., Grisoli F., Vagner-Capodano A.M. Hidden chromosome abnormalities in a primary central nervous system lymphoma detected by multicolor spectral karyotyping. Cancer Genet Cytogenet. 107:1998;98-101.
17. Fleischman E.W., Reshmi S., Sokova O.I., Kirichenko O.P., Konstantinova L.N., Kulagina O.E., Frenkel M.A., Rowley J.D. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet. 108:1999;166-170.
18. ISCN. An international system for human cytogenetic nomenclature. F. Mitelman, editor. Basel: S. Karger, 1995.
19. Esa A., Trakhtenbrot L., Hausmann M., Rauch J., Brok-Simoni F., Rechavi G., Ben-Bassat I., Cremer C. Fast-FISH detection and semi-automated image analysis of numerical chromosome aberrations in hematological malignancies. Anal Cell Pathol. 16:1998;211-222.
20. Heim S, Mitelman F. Cancer Cytogenetics. Wiley-Liss, Inc., 1995.
21. Archimbaud E., Charrin C., Magaud J.P., Campos L., Thomas X., Fiere D., Rimokh R. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly. confirmation of the existence of different entities with 11q23 breakpoint Leukemia. 12:1998;25-33.
22. Schichman S.A., Caligiuri M.A., Gu Y., Strout M.P., Canaani E., Bloomfield C.D., Croce C.M. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA. 91:1994;6236-6239.